Type 2 diabetes tied to accelerated brain aging, cognitive decline
Jun 08, 2022
The authors say the neurological impact may start before diabetes is formally diagnosed.
Metformin, lifestyle changes cut risk for T2DM, but not CVD
May 27, 2022
No reduction seen in first occurrence of nonfatal MI, stroke, or CV death with either metformin or lifestyle intervention versus placebo
Effects of intranasal insulin on cognition, mobility studied in elderly
May 05, 2022
Evidence from a phase 2 trial suggests positive effects on cognition and gait in elderly patients with type 2 diabetes.
BP genetic risk score linked to risk for CV events in type 2 diabetes
Apr 04, 2022
Each standard deviation increase in BP polygenic risk score was linked to a 12% increased hazard of adverse cardiovascular events.
Diabetic eye complications more common in Blacks, Hispanics
Apr 01, 2022
Additionally, minorities are less likely to receive all recommended diabetes care.
Hypertension, type 2 diabetes contribute to brain changes in Puerto Rican seniors
Apr 01, 2022
A high prevalence of hypertension and type 2 diabetes was seen among the Puerto Rican cohort; those with both have deteriorating patterns in major white matter tracts.
House passes bill to limit insulin costs to $35 a month
Apr 01, 2022
The bill now has to pass the Senate with at least 10 Republican votes.
GLP-1 RA use may up risk for gallbladder, biliary diseases
Mar 31, 2022
Treatment with GLP-1 RA, used for diabetes and weight loss, was linked to an increased risk, especially in trials for weight loss, and with higher doses and longer duration of use.
Risk, burden of diabetes up after acute SARS-CoV-2 infection
Mar 30, 2022
The risks and burdens of postacute outcomes increased in graded manner based on COVID-19 severity.
Overtreatment of T2DM common among VA nursing home residents
Mar 25, 2022
A minority of those overtreated or potentially overtreated have their medication regimens appropriately deintensified.
